Ed Silverman
19 stories across 1 outlet
STAT News 22
SpotlightBusiness & FinanceData & Analysis
Published work
STAT+: Licensing deals on generic versions of Roche flu drug aimed at preparing for pandemic
STAT News - Spotlight
STAT+: Pharmalittle: We’re reading about a reticent FDA commish nominee, a Novo deal, and more
STAT News - Spotlight
STAT+: Up and down the ladder: The latest comings and goings
STAT News - Spotlight
STAT+: Indonesian ruling against ‘patent evergreening’ by pharma industry sends critical message, patient advocates say
STAT News - Spotlight
STAT+: Pharmalittle: We’re reading about the FDA commissioner nominee, a Lilly partnership in China, and more
STAT News - Spotlight
STAT+: Pharmalittle: We’re reading about an AstraZeneca COPD win, the FDA filling key jobs, and more
STAT News - Spotlight
STAT+: The gifts from pharma companies that keep on giving
STAT News - Spotlight
STAT+: Pharmalittle: We’re reading about a Novartis investor seeking a shake-up, a Gilead setback, and more
STAT News - Business & Finance
STAT+: Cancer medicines remain in short supply across the U.S., survey finds
STAT News - Data & Analysis
STAT+: Pharmalittle: We’re reading about anxious Novartis investors, patent expirations for biologics, and more
STAT News - Spotlight
STAT+: Pharma wins a battle over the cost of wastewater treatment in Europe
STAT News - Spotlight
STAT+: Pharmalittle: We’re reading about another AstraZeneca trial failure, a Novo name change, and more
STAT News - Spotlight
STAT+: Trump’s secretive pharma deals may undermine ‘most-favored nation’ pricing, an analysis suggests
STAT News - Spotlight
STAT+: Pharmalittle: We’re reading about a GSK deal for a drug from China, job losses in the U.S., and more
STAT News - Spotlight
STAT+: Pharmalittle: We’re reading about faster FDA approvals, access to experimental drugs in Montana, and more
STAT News - Spotlight
STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more
STAT News - Spotlight
STAT+: Pharmalittle: We’re reading about pharma seeking to protect China deals, a Roche obesity drug, and more
STAT News - Spotlight
STAT+: HHS unveils new initiatives to reduce animal testing in drug development
STAT News - Spotlight